Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

63.35
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
42.23
Today|||52-Week Range
65.81
+4.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues38.2M36.6M44.8M48.2M
 
 
 
 
 
Cost of Goods Sold16.9M16.4M21.1M21.1M
 
 
 
 
 
Depreciation And Amortization5.8M6.7M7.1M7.1M
 
 
 
 
 
 
Operating ExpensesGross Income15.5M13.5M16.5M20.0M
 
 
 
 
 
General Expenses7.5M8.9M9.5M10.7M
 
 
 
 
 
Research And Development135.0K1.6M2.2M2.6M
 
 
 
 
 
Total Operating Expenses30.2M32.0M37.8M38.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.0M4.6M7.0M9.3M
 
 
 
 
 
Extraordinary Charge-6.7M0.000.000.00
 
 
Interest Expense On Debt2.9M3.0M3.2M3.2M
 
 
 
 
 
Other Expenses-43.0K-18.0K-19.0K95.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M1.7M4.0M6.4M
 
 
 
 
 
Income Taxes-524.0K-523.0K-1.3M-1.7M
 
 
 
 
 
Net Income-1.1M1.1M2.7M4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.5M11.5M11.5M11.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.5M11.7M11.7M11.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09$0.10$0.23$0.40
 
 
 
 
 
EPS Diluted-$0.09$0.10$0.23$0.40